AstraZeneca COVID vaccine candidate moves to new human trial phase with billion dollars in U.S. taxpayer backing
8:25am PDT - May 22nd, 2020 astrazeneca - CBS NewsOxford University team to give 10,000 people in 3 age groups a dose of their trial COVID-19 vaccine, and U.S. taxpayers have a big bet on it working.